Trial Profile
Efficacy of Rivastigmine Transdermal Patch in Dementia Patients who do not benefit from Oral Acetylcholinesterase Inhibitors (AChIs).
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2013
Price :
$35
*
At a glance
- Drugs Rivastigmine (Primary)
- Indications Dementia
- Focus Therapeutic Use
- 21 Oct 2010 New trial record